SAN CARLOS, Calif.--(BUSINESS WIRE)--Deltagen, Inc. (Pink Sheets:DGEN), a leading provider of drug discovery tools to the biopharmaceutical industry, today reported financial results for the three months ended June 30, 2006.
SAN CARLOS, Calif.--(BUSINESS WIRE)--Deltagen, Inc. (Pink Sheets:DGEN), a leading provider of drug discovery tools to the biopharmaceutical industry, today reported financial results for the three months ended June 30, 2006.
